Insiders · SAGE

Albert Robichaud

Officer at Sage Therapeutics, Inc. (SAGE)

Albert Robichaud has filed 6 insider reports with the SEC since February 2021, as officer at Sage Therapeutics, Inc. (SAGE). The latest filing, on February 15, 2023, reports grant or award at Sage Therapeutics, Inc. (SAGE).

Filings
6
Companies
1
Bought on market
None
Sold on market
None

Companies where Albert Robichaud is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Sage Therapeutics, Inc. logo
SAGE
Sage Therapeutics, Inc.
Officer145,553Feb 15, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Albert Robichaud with

Other insiders at the same companies

Questions about Albert Robichaud

What is Albert Robichaud's role at Sage Therapeutics, Inc.?
Albert Robichaud reports to the SEC as officer at Sage Therapeutics, Inc. (SAGE), according to the latest filing on February 15, 2023.
How many shares does Albert Robichaud own?
After the latest filing that states it, Albert Robichaud directly owned 145,553 shares of Sage Therapeutics, Inc. (SAGE). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Albert Robichaud bought or sold stock recently?
No open-market purchases or sales by Albert Robichaud are on file. The filings report grant or award and shares withheld for taxes or exercise price.
How do I get alerts when Albert Robichaud files?
Follow Albert Robichaud on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Albert Robichaud (SEC CIK 0001612861). Totals count each trade once, skipping amendments whose original is on file, from Feb 12, 2021 on. View on SEC EDGAR · Get this as JSON